The care of neonates treated in neonatal intensive care units (NICUs) is a complex undertaking, making the use of medications a challenge. Prescribers must take care in assessing the impact of various medications on neonate health. This module examines the impact of weight, body composition, genetics and other factors in neonatal medication use. It also discusses the use of specific medications in neonates, the determinants of neonate drug responses, and various challenges in neonatal clinical pharmacology, including drug absorption and other issues.
Length of Module: 40 minutes 33 seconds
How to Use the Module
Begin by completing the self-assessment. This will determine your current level of understanding about ADRs.
Next, watch the video presentation of the module.
When you have completed the video presentation, visit the case study and answer the questions.
Finally, for additional learning, access the resources and references document, which includes further information to expand your knowledge about ADRs.
When you have completed all steps, it is recommended that you return to the self-assessment and test your knowledge again.
About the Presenter
Dr. van den Anker is Vice Chair of Pediatrics for Experimental Therapeutics and Director of Pediatric Clinical Pharmacology at Children’s National Medical Center in Washington, D.C. He is also Professor of Pediatrics, Pharmacology and Physiology at George Washington University School of Medicine and Health Sciences, where he holds the Evan and Cindy Jones Chair in Pediatric Clinical Pharmacology. An expert in pediatric clinical pharmacology, Dr. van den Anker has received several major research awards from the National Institute of Health (NIH) and has published more than 250 peer reviewed papers in the field of neonatal and pediatric clinical pharmacology.
Presented by the PhRMA Foundation Safe and Effective Prescribing Project
For more information, please call 202-572-7756